Skip Navigation


Glycobiology Advance Access originally published online on November 1, 2002
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
13/2/119    most recent
cwg010v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (27)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Correa, S. G.
Right arrow Articles by Rabinovich, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Correa, S. G.
Right arrow Articles by Rabinovich, G. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Glycobiology, 2003, Vol. 13, No. 2 119-128
© 2003 Oxford University Press

Opposite effects of galectin-1 on alternative metabolic pathways of L-arginine in resident, inflammatory, and activated macrophages

Silvia G. Correa2, Claudia E. Sotomayor2, María P. Aoki3, Cristina A. Maldonado3 and Gabriel A. Rabinovich14

2 Immunology, Department of Clinical Biochemistry, School of Chemical Sciences, National University of Córdoba, Calle Haya De La Torre Esquina Medina Allende (C. 5000), Córdoba, Argentina
3 Centre of Electron Microscopy, School of Medicine, National University of Córdoba,Casilla Postal 362 (C. 5000), Cordóba, Argentina
4 Division of Immunogenetics, Hospital de Clínicas "José de San Martín," School of Medicine, University of Buenos Aires, Av. Córdoba 2351, 3erPiso, Sala 4 (C. 1120) Ciudad de Buenos Aires, Argentina

Received on June 29, 2002; revised on September 8, 2002; accepted on September 10, 2002

Recent evidence has implicated galectins and their carbohydrate ligands as master regulators of the inflammatory response. Galectin-1, a member of this family, has shown specific anti-inflammatory and immunoregulatory effects. To gain insight into the potential mechanisms involved in these effects, we investigated the effects of galectin-1 in L-arginine metabolism of peritoneal rat macrophages. Pretreatment of macrophages with galectin-1 resulted in a dose- and time-dependent inhibition of lipopolysaccharide-induced nitric oxide (NO) production, accompanied by a decrease in inducible nitric oxide synthase (iNOS) expression (the classic pathway of L-arginine). On the other hand, galectin-1 favored the balance toward activation of L-arginase, the alternative metabolic pathway of L-arginine. Inhibition of NO production was not the result of increased macrophage apoptosis because addition of this ß-galactoside-binding protein to macrophages under the same experimental conditions did not affect the apoptotic threshold of these cells. To understand how endogenous galectin-1 is regulated in macrophages under inflammatory stress, we finally explored the ultrastructural distribution, expression, and secretion of galectin-1 in resident, inflammatory, and activated macrophages. This study provides an alternative cellular mechanism based on the modulation of L-arginine metabolism to understand the molecular basis of the anti-inflammatory properties displayed by this carbohydrate-binding protein.

1 To whom correspondence should be addressed; e-mail: gabyrabi{at}ciudad.com.ar


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
P. Barrionuevo, M. Beigier-Bompadre, J. M. Ilarregui, M. A. Toscano, G. A. Bianco, M. A. Isturiz, and G. A. Rabinovich
A Novel Function for Galectin-1 at the Crossroad of Innate and Adaptive Immunity: Galectin-1 Regulates Monocyte/Macrophage Physiology through a Nonapoptotic ERK-Dependent Pathway
J. Immunol., January 1, 2007; 178(1): 436 - 445.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. Case, D. Irwin, C. Ivester, J. Harral, K. Morris, M. Imamura, M. Roedersheimer, A. Patterson, M. Carr, M. Hagen, et al.
Mice deficient in galectin-1 exhibit attenuated physiological responses to chronic hypoxia-induced pulmonary hypertension
Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L154 - L164.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. A. Fulcher, S. T. Hashimi, E. L. Levroney, M. Pang, K. B. Gurney, L. G. Baum, and B. Lee
Galectin-1-Matured Human Monocyte-Derived Dendritic Cells Have Enhanced Migration through Extracellular Matrix
J. Immunol., July 1, 2006; 177(1): 216 - 226.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Toscano, A. G. Commodaro, J. M. Ilarregui, G. A. Bianco, A. Liberman, H. M. Serra, J. Hirabayashi, L. V. Rizzo, and G. A. Rabinovich
Galectin-1 Suppresses Autoimmune Retinal Disease by Promoting Concomitant Th2- and T Regulatory-Mediated Anti-Inflammatory Responses
J. Immunol., May 15, 2006; 176(10): 6323 - 6332.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
G. Gatti, V. Rivero, R. D. Motrich, and M. Maccioni
Prostate epithelial cells can act as early sensors of infection by up-regulating TLR4 expression and proinflammatory mediators upon LPS stimulation
J. Leukoc. Biol., May 1, 2006; 79(5): 989 - 998.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
J M Ilarregui, G A Bianco, M A Toscano, and G A Rabinovich
The coming of age of galectins as immunomodulatory agents: impact of these carbohydrate binding proteins in T cell physiology and chronic inflammatory disorders
Ann Rheum Dis, November 1, 2005; 64(suppl_4): iv96 - iv103.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. He and L. G. Baum
Presentation of Galectin-1 by Extracellular Matrix Triggers T Cell Death
J. Biol. Chem., February 6, 2004; 279(6): 4705 - 4712.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.